Clinical Trial Update: Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 safety study of a single-administration post-exposure prophylaxis treatment for Marburg virus, sponsored by Sare…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Marburg Hemorrhagic Fever

Snippet

Sponsor: Sarepta Therapeutics, Inc. | Conditions: Marburg Hemorrhagic Fever | Phase 1 | Status: COMPLETED